查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1546239

全球辐射剂量管理市场

Radiation Dose Management
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球辐射剂量管理市场预计将达到 8.352 亿美元

全球辐射剂量管理市场预计 2023 年为 3.411 亿美元，预计到 2030 年将达到 8.352 亿美元，2023-2030 年分析期间复合年增长率为 13.6%。辐射剂量管理解决方案是本报告分析的细分市场之一，预计复合年增长率为 14.0%，到分析期结束时将达到 4.796 亿美元。分析期间辐射剂量管理服务业的复合年增长率预计为 13.2%。

美国市场预计9,200万美元，中国预计复合年增长率12.7%

预计2023年美国辐射剂量控制市场规模将达9,200万美元。中国作为世界第二大经济体，预计2030年市场规模将达到1.263亿美元，2023-2030年分析期间复合年增长率为12.7%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 12.3% 和 11.3%。在欧洲，德国的复合年增长率预计约为 9.8%。

全球辐射剂量管理市场 - 主要趋势和驱动因素总结

辐射剂量管理：确保医学影像诊断中的病人安全

辐射剂量管理是指在 X 光、 电脑断层扫描和核子医学等医学影像处理过程中监测、管理和优化病患辐射暴露的系统方法。此过程对于确保患者安全同时实现准确医疗评估所需的诊断品质至关重要。过度的辐射暴露会增加癌症等不良健康影响的风险，因此必须在保持诊断资讯完整性的同时最大限度地减少辐射暴露。辐射剂量管理系统旨在追踪辐射剂量，提醒医疗保健专业人员潜在的过度暴露，并实施最佳实践来优化辐射使用。随着诊断成像的使用在全球范围内不断增加，此类系统的实施变得越来越重要。

技术进步如何改善辐射剂量控制？

技术进步显着改善了辐射剂量管理系统，使其更有效率、准确，并整合到医疗保健工作流程中。最新的系统结合了先进的分析和机器学习演算法，可以即时分析辐射剂量资料，向医疗保健提供者提供即时回馈。这些系统可以根据患者体型、年龄和特定诊断要求自动调整成像通讯协定，在不影响影像品质的情况下最大限度地减少不必要的辐射暴露。透过整合辐射剂量管理系统和电子健康记录(EHR)，可以无缝记录和追踪患者的辐射历史，从而实现对未来诊断成像的更个人化和明智的决策。此外，剂量优化软体的进步使得不同成像设备之间的通讯协定标准化成为可能，从而确保整个医疗机构辐射管理的一致性。这些技术进步正在促进先进辐射剂量管理系统的实施，提高病人安全并改善医学影像结果。

辐射剂量管理在医学影像诊断的主要用途和好处是什么？

辐射剂量管理系统用于各种诊断成像模式，并具有许多好处，可以提高患者安全性、遵守监管标准以及医疗保健的整体品质。在诊断放射学中，它有助于监测和减少电脑断层扫描，众所周知，与其他影像技术相比，CT 扫描的辐射剂量相对较高。在介入放射学中，通常需要长时间暴露，而辐射剂量控制对于保护患者和医护人员免受过度辐射至关重要。辐射剂量控制在儿科影像诊断中也很有效，其中最大限度地减少辐射暴露尤其重要，因为儿童对辐射高度敏感。此外，辐射剂量管理系统支援遵守核能(IAEA) 和欧洲核能共同体 (Euratom) 等国际标准和法规，确保医疗保健提供者满足安全要求。辐射剂量管理的主要好处包括提高病人安全性、改善临床决策以及降低辐射引起的併发症的风险，使其成为现代医学影像的重要组成部分。

推动辐射剂量管理市场成长的因素有哪些？

辐射剂量管理市场的成长受到多种因素的推动。医疗保健专业人员和患者对辐射安全的认识不断提高，这主要是由于关注尽量减少医学影像期间的辐射暴露。剂量管理软体、资料分析和机器学习等技术进步也透过提高这些系统的准确性和效率来推动市场成长。全球范围内诊断成像程序数量的不断增加，特别是在老龄化社会中，进一步推动了对辐射剂量管理解决方案的需求。此外，有关辐射安全的严格监管要求和认证标准也促进了市场的成长。医疗保健提供者正在尝试透过实施先进的剂量管理系统来遵守这些法规。此外，电子健康记录(EHR) 的日益普及以及剂量管理系统与 EHR 的整合也支持了市场扩张。这些因素加上医疗保健技术的持续创新，正在推动辐射剂量管理市场的持续成长。

调查企业举例（共11家）

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum NV
  • Sectra AB
  • Siemens Healthineers

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP14319

Global Radiation Dose Management Market to Reach US$835.2 Million by 2030

The global market for Radiation Dose Management estimated at US$341.1 Million in the year 2023, is expected to reach US$835.2 Million by 2030, growing at a CAGR of 13.6% over the analysis period 2023-2030. Radiation Dose Management Solutions, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$479.6 Million by the end of the analysis period. Growth in the Radiation Dose Management Services segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.0 Million While China is Forecast to Grow at 12.7% CAGR

The Radiation Dose Management market in the U.S. is estimated at US$92.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$126.3 Million by the year 2030 trailing a CAGR of 12.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.3% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Radiation Dose Management Market - Key Trends and Drivers Summarized

Radiation Dose Management: Ensuring Patient Safety in Medical Imaging

Radiation dose management refers to the systematic approach to monitoring, controlling, and optimizing the amount of radiation exposure patients receive during medical imaging procedures such as X-rays, CT scans, and nuclear medicine. This process is crucial in ensuring patient safety while achieving the diagnostic quality necessary for accurate medical evaluations. Excessive radiation exposure can increase the risk of adverse health effects, including cancer, making it essential to minimize exposure while maintaining the integrity of the diagnostic information. Radiation dose management systems are designed to track radiation doses, alert healthcare providers to potentially excessive exposure levels, and implement best practices to optimize radiation use. The implementation of these systems is becoming increasingly important as the use of diagnostic imaging continues to grow worldwide.

How Are Technological Advancements Enhancing Radiation Dose Management?

Technological advancements have significantly improved radiation dose management systems, making them more efficient, precise, and integrated into healthcare workflows. Modern systems now incorporate advanced analytics and machine learning algorithms that analyze radiation dose data in real-time, providing immediate feedback to healthcare providers. These systems can automatically adjust imaging protocols based on patient size, age, and the specific diagnostic requirement, thereby minimizing unnecessary exposure without compromising image quality. The integration of radiation dose management systems with electronic health records (EHRs) allows for seamless documentation and tracking of patient radiation histories, enabling more personalized and informed decisions about future imaging procedures. Additionally, advancements in dose optimization software have made it possible to standardize protocols across different imaging devices, ensuring consistency in radiation management across a healthcare facility. These technological improvements are driving the adoption of sophisticated radiation dose management systems, enhancing patient safety and improving outcomes in medical imaging.

What Are the Key Applications and Benefits of Radiation Dose Management in Medical Imaging?

Radiation dose management systems are utilized across various imaging modalities, offering numerous benefits that enhance patient safety, compliance with regulatory standards, and overall healthcare quality. In diagnostic radiology, these systems help monitor and reduce radiation exposure during CT scans, which are known for their relatively high radiation doses compared to other imaging techniques. In interventional radiology, where procedures often involve prolonged exposure times, radiation dose management is critical for protecting both patients and healthcare staff from excessive radiation. The systems are also valuable in pediatric imaging, where minimizing radiation exposure is particularly important due to the increased sensitivity of children to radiation. Furthermore, radiation dose management systems support compliance with international standards and regulations, such as those set by the International Atomic Energy Agency (IAEA) and the European Atomic Energy Community (Euratom), ensuring that healthcare providers meet safety requirements. The primary benefits of radiation dose management include enhanced patient safety, improved clinical decision-making, and reduced risk of radiation-induced complications, making it an essential component of modern medical imaging practices.

What Factors Are Driving the Growth in the Radiation Dose Management Market?

The growth in the Radiation Dose Management market is driven by several factors. The increasing awareness of radiation safety among healthcare providers and patients is a significant driver, as more emphasis is placed on minimizing radiation exposure during medical imaging. Technological advancements in dose management software, data analytics, and machine learning are also propelling market growth by improving the precision and efficiency of these systems. The rising number of diagnostic imaging procedures worldwide, particularly in aging populations, is further boosting demand for radiation dose management solutions, as these systems are essential for ensuring patient safety in high-volume imaging environments. Additionally, stringent regulatory requirements and accreditation standards related to radiation safety are contributing to market growth, as healthcare providers seek to comply with these regulations by implementing advanced dose management systems. The growing adoption of electronic health records (EHRs) and the integration of dose management systems with EHRs are also supporting market expansion, as these technologies enable better tracking and optimization of radiation exposure. These factors, combined with continuous innovation in healthcare technology, are driving the sustained growth of the Radiation Dose Management market.

Select Competitors (Total 11 Featured) -

  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum N.V.
  • Sectra AB
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Radiation Dose Management - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Patient Safety and Radiation Protection Propels Market Growth
    • Technological Advancements in Dose Tracking and Monitoring Software Strengthen Market Position
    • Growing Adoption of Digital Health Records Drives Integration of Dose Management Systems
    • Surge in Demand for Dose Management Solutions in Diagnostic Imaging Generates New Opportunities
    • Development of AI and Machine Learning-Based Dose Optimization Sustains Market Growth
    • Expanding Applications in Interventional Radiology Throws Spotlight on Market Potential
    • Growth in Radiology Practices and Imaging Centers Spurs Demand for Dose Management
    • Increasing Awareness of Radiation-Induced Health Risks Strengthens Business Case
    • Rising Adoption of Cloud-Based Dose Management Solutions Propels Market Expansion
    • Surge in Demand for Automated Dose Monitoring in Radiation Therapy Expands Market Horizons
    • Growing Emphasis on Compliance with International Radiation Safety Standards Drives Market Adoption
    • Innovations in Real-Time Dose Monitoring and Reporting Generate New Market Opportunities
    • Rising Demand for Dose Management in Pediatric and Geriatric Imaging Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Radiography & Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Radiography & Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Nuclear Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 11: World Radiation Dose Management Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Fluoroscopy & Interventional Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Fluoroscopy & Interventional Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Canada 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • JAPAN
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: Japan 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 37: Japan 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • CHINA
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: China 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: China 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • EUROPE
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • FRANCE
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: France 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: France 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • GERMANY
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Germany 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Germany 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Italy 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Italy 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • UNITED KINGDOM
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 73: UK 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 77: UK 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Radiation Dose Management Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Rest of World 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Nuclear Medicine, Fluoroscopy & Interventional Imaging and Radiography & Mammography for the Years 2024 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Other End-Uses for the Years 2024 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Radiation Dose Management by Component - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Rest of World 7-Year Perspective for Radiation Dose Management by Component - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2024 & 2030

IV. COMPETITION